1. Home
  2. LFMD vs ESPR Comparison

LFMD vs ESPR Comparison

Compare LFMD & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$3.99

Market Cap

330.5M

Sector

Health Care

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.96

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMD
ESPR
Founded
1994
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
330.5M
898.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
LFMD
ESPR
Price
$3.99
$3.96
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
$10.22
$6.67
AVG Volume (30 Days)
1.1M
6.5M
Earning Date
11-17-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$250,091,814.00
$303,802,000.00
Revenue This Year
$13.65
$25.45
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
28.78
2.83
52 Week Low
$3.18
$0.69
52 Week High
$15.84
$4.13

Technical Indicators

Market Signals
Indicator
LFMD
ESPR
Relative Strength Index (RSI) 55.20 59.47
Support Level $3.21 $3.63
Resistance Level $3.45 $4.13
Average True Range (ATR) 0.20 0.20
MACD 0.11 -0.02
Stochastic Oscillator 100.00 64.00

Price Performance

Historical Comparison
LFMD
ESPR

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: